M R22 (Repaglinide 1 mg)
Pill imprint M R22 has been identified as Repaglinide 1 mg.
Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 1 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about repaglinide
- Other brands: Prandin
Related treatment guides
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.